(Reuters) – The World Health Organization’s advisory panel on Friday recommended extending the use of Pfizer and German Partner BioNTech’s COVID-19 vaccine to include children aged 5 to 11 years old.
The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Wednesday to evaluate the companies’ vaccine. The vaccine is currently recommended for use in people aged 12 years and above.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Mark Heinrich)
